4-7433556-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001085382.2(PSAPL1):​c.1324G>A​(p.Val442Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000587 in 1,611,104 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00050 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00060 ( 2 hom. )

Consequence

PSAPL1
NM_001085382.2 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.682

Publications

2 publications found
Variant links:
Genes affected
PSAPL1 (HGNC:33131): (prosaposin like 1) This gene encodes a protein that is related to the glycoprotein prosaposin. Based on sequence similarity between the encoded protein and prosaposin, it is predicted that the encoded protein is a preproprotein that is proteolytically processed to generate multiple protein products. These predicted products include saposins A-like, B-like, C-like, and D-like, which may play a role in the lysosomal degradation of sphingolipids. [provided by RefSeq, Jul 2015]
SORCS2 (HGNC:16698): (sortilin related VPS10 domain containing receptor 2) This gene encodes one family member of vacuolar protein sorting 10 (VPS10) domain-containing receptor proteins. The VPS10 domain name comes from the yeast carboxypeptidase Y sorting receptor Vps10 protein. Members of this gene family are large with many exons but the CDS lengths are usually less than 3700 nt. Very large introns typically separate the exons encoding the VPS10 domain; the remaining exons are separated by much smaller-sized introns. These genes are strongly expressed in the central nervous system. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05408886).
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSAPL1NM_001085382.2 linkc.1324G>A p.Val442Ile missense_variant Exon 1 of 1 ENST00000319098.7 NP_001078851.1 Q6NUJ1
SORCS2NM_020777.3 linkc.548+37201C>T intron_variant Intron 2 of 26 ENST00000507866.6 NP_065828.2 Q96PQ0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSAPL1ENST00000319098.7 linkc.1324G>A p.Val442Ile missense_variant Exon 1 of 1 6 NM_001085382.2 ENSP00000317445.4 Q6NUJ1
SORCS2ENST00000507866.6 linkc.548+37201C>T intron_variant Intron 2 of 26 1 NM_020777.3 ENSP00000422185.2 Q96PQ0
SORCS2ENST00000511199.1 linkn.163+37201C>T intron_variant Intron 2 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.000480
AC:
73
AN:
152190
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000705
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000381
AC:
93
AN:
244138
AF XY:
0.000370
show subpopulations
Gnomad AFR exome
AF:
0.000531
Gnomad AMR exome
AF:
0.0000587
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000677
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000615
Gnomad OTH exome
AF:
0.000336
GnomAD4 exome
AF:
0.000596
AC:
869
AN:
1458796
Hom.:
2
Cov.:
63
AF XY:
0.000573
AC XY:
416
AN XY:
725548
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33440
American (AMR)
AF:
0.0000450
AC:
2
AN:
44426
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26084
East Asian (EAS)
AF:
0.000328
AC:
13
AN:
39620
South Asian (SAS)
AF:
0.000152
AC:
13
AN:
85802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52372
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.000670
AC:
744
AN:
1110994
Other (OTH)
AF:
0.00139
AC:
84
AN:
60292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000499
AC:
76
AN:
152308
Hom.:
2
Cov.:
33
AF XY:
0.000389
AC XY:
29
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41574
American (AMR)
AF:
0.000261
AC:
4
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5168
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000706
AC:
48
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000773
Hom.:
0
Bravo
AF:
0.000468
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000234
AC:
1
ESP6500EA
AF:
0.000472
AC:
4
ExAC
AF:
0.000388
AC:
47
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 09, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1324G>A (p.V442I) alteration is located in exon 1 (coding exon 1) of the PSAPL1 gene. This alteration results from a G to A substitution at nucleotide position 1324, causing the valine (V) at amino acid position 442 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.036
T
Eigen
Benign
0.11
Eigen_PC
Benign
-0.062
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.47
T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.054
T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.68
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.77
N
REVEL
Uncertain
0.41
Sift
Benign
0.071
T
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.14
MVP
0.97
MPC
0.20
ClinPred
0.022
T
GERP RS
3.4
Varity_R
0.077
gMVP
0.22
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199523405; hg19: chr4-7435283; COSMIC: COSV106100699; API